The varieties of psychosis in multiple sclerosis: A systematic review of cases.

Carlos R Camara-Lemarroy, Beatriz E Ibarra-Yruegas, Rene Rodriguez-Gutierrez, Idanis Berrios-Morales, Carolina Ionete, Peter Riskind

Journal: Multiple sclerosis and related disorders 2017;12():9-14

PMID: 28283114

Abstract

OBJECTIVES

Multiple Sclerosis (MS) is known to be associated with a wide range of psychiatric symptoms, particularly with affective disorders. However, a link to psychotic disorders has not been fully established.

METHODS

A systematic review of the PubMed/MEDLINE database was performed to identify cases of MS presenting with psychotic symptoms. Variables analyzed included patient demographics, clinical presentation, imaging characteristics and treatment.

RESULTS

Ninety-one cases were identified. The mean age was 34.4, and there was a female predominance. The majority of patients did not have a prior history of MS or psychiatric disease. The majority of cases could be classified as having either Psychotic Disorders or Mood Disorders with psychotic features. Most patients received some type of antipsychotic therapy, with variable success. At least 26 patients were treated with corticosteroids in the acute phase of their psychotic symptoms, and the majority responded favorably. Imaging data was available for 50 patients. Of these, 60% had predominantly fronto-temporal lesions, and most had contrast enhancing lesions.

CONCLUSIONS

MS can present with a variety of psychotic symptoms. The presence of enhancing lesions and steroid-responsiveness suggests these could be characterized as flares.

Copyright © 2016 Elsevier B.V. All rights reserved.

Address: Neurology Service. University Hospital, "Dr. Jose E. Gonzalez", Autonomous University of Nuevo Leon, Monterrey, Mexico. Electronic address: [email protected].; Neurology Service. University Hospital, "Dr. Jose E. Gonzalez", Autonomous University of Nuevo Leon, Monterrey, Mexico.; Division of Endocrinology, University Hospital "Dr. Jose E. Gonzalez", Autonomous University of Nuevo Leon, Monterrey, Mexico; Knowledge and Evaluation Research Unit, Division of Endocrinology, Diabetes, Metabolism and Nutrition, Department of Medicine, Mayo Clinic, Rochester, MN, USA.; Department of Neurology, Multiple sclerosis Center, University of Massachusetts Memorial Medical Center, Worcester, MA, USA.

Link outs

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.